Vifor Pharma AG
F:G2AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vifor Pharma AG
F:G2AB
|
CH |
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
T
|
Tabcorp Holdings Ltd
DUS:THL
|
AU |
|
C
|
City Developments Ltd
XMUN:CDE
|
SG |
|
A
|
Asia Sermkij Leasing PCL
SET:ASK
|
TH |
Dividends
Dividend Yield
Vifor Pharma AG
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Vifor Pharma AG
Payout Ratio
Vifor Pharma AG
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for G2AB is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
G2AB Price
Vifor Pharma AG
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -25% |
| Market Capitalization | 10.8B EUR |
| Shares Outstanding | 324 456 992 |
| Percentage of Shares Shorted |
N/A
|
